Want to join the conversation?
$MYL and and Biocon, which have co-developed this proposed biosimilar, expect that this may be first MAA for Trastuzumab biosimilar accepted by EMA for review. This filing includes analytical, functional and pre-clinical data, as well as results from pharmacokinetics (PK) and confirmatory efficacy/safety global clinical trials for Trastuzumab.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!